Completed OBSERVATIONAL NCT05397015

Metabotyping in the Postmenopausal Stage (SHE-HEALTH)

Metabotyping in the Postmenopausal Stage: Cross-Sectional Observational Study

Sponsor: Fundació Eurecat

Conditions Menopause Postmenopausal Disorder Postmenopausal Symptoms

Interventions No intervention will be done

Updated 4 times since 2022 Last updated: Mar 15, 2023 Started: Apr 16, 2021 Primary completion: Nov 29, 2022 Completion: Nov 29, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Menopause and Postmenopausal Disorder and is currently completed. Fundació Eurecat leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Apr 2023 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Jun 2022 — Apr 2023 [monthly]

Recruiting

First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundació Eurecat

Data source: Fundació Eurecat

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Reus, Spain